Insights into the mechanisms of diabetic wounds: pathophysiology, molecular targets, and treatment strategies through conventional and alternative therapies
- 11 January 2024
- journal article
- review article
- Published by Springer Nature in Inflammopharmacology
- Vol. 32 (1) , 149-228
Abstract
Diabetes mellitus is a prevalent cause of mortality worldwide and can lead to several secondary issues, including DWs, which are caused by hyperglycemia, diabetic neuropathy, anemia, and ischemia. Roughly 15% of diabetic patient’s experience complications related to DWs, with 25% at risk of lower limb amputations. A conventional management protocol is currently used for treating diabetic foot syndrome, which involves therapy using various substances, such as bFGF, pDGF, VEGF, EGF, IGF-I, TGF-β, skin substitutes, cytokine stimulators, cytokine inhibitors, MMPs inhibitors, gene and stem cell therapies, ECM, and angiogenesis stimulators. The protocol also includes wound cleaning, laser therapy, antibiotics, skin substitutes, HOTC therapy, and removing dead tissue. It has been observed that treatment with numerous plants and their active constituents, including Globularia Arabica, Rhus coriaria L., Neolamarckia cadamba, Olea europaea, Salvia kronenburgii, Moringa oleifera, Syzygium aromaticum, Combretum molle, and Myrtus communis, has been found to promote wound healing, reduce inflammation, stimulate angiogenesis, and cytokines production, increase growth factors production, promote keratinocyte production, and encourage fibroblast proliferation. These therapies may also reduce the need for amputations. However, there is still limited information on how to prevent and manage DWs, and further research is needed to fully understand the role of alternative treatments in managing complications of DWs. The conventional management protocol for treating diabetic foot syndrome can be expensive and may cause adverse side effects. Alternative therapies, such as medicinal plants and green synthesis of nano-formulations, may provide efficient and affordable treatments for DWs. Graphical abstractKeywords
This publication has 371 references indexed in Scilit:
- A review: Anti diabetic medicinal plants used for diabetes mellitusJournal of Acute Disease, 2013
- Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment CapabilitiesPLOS ONE, 2012
- Plectranthus amboinicusandCentella asiaticaCream for the Treatment of Diabetic Foot UlcersEvidence-Based Complementary and Alternative Medicine, 2012
- Management of Diabetic Foot UlcersDiabetes Therapy, 2012
- Debridement of diabetic foot woundsNursing Standard, 2012
- Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patientsInternational Journal Of Clinical Practice, 2012
- Infections in patients with diabetes mellitus: A review of pathogenesisIndian Journal of Endocrinology and Metabolism, 2012
- Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic woundsProceedings of the National Academy of Sciences, 2010
- Cellular and molecular basis of wound healing in diabetesJournal of Clinical Investigation, 2007
- Decreased Macrophage Number and Activation Lead to Reduced Lymphatic Vessel Formation and Contribute to Impaired Diabetic Wound HealingThe American Journal of Pathology, 2007